A Review of Antifungal Susceptibility Testing for Dermatophyte Fungi and It's Correlation with Previous Exposure and Clinical Responses.

Author: HayRoderick James, KhanSidra Saleem, SaunteDitte Marie Lindhardt

Paper Details 
Original Abstract of the Article :
<b>Background:</b> An increase in the number of recurrent and recalcitrant dermatophytoses calls for a tool to guide the clinician to correlate in vitro minimum inhibitory concentration (MIC) data, antifungal treatment with clinical outcomes. This systematic review aims to explore a possible correl...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785514/

データ提供:米国国立医学図書館(NLM)

Antifungal Susceptibility Testing: Navigating the Desert of Dermatophyte Infections

The realm of dermatophyte infections, my dear friend, is a vast and complex desert, filled with diverse species of fungi that can cause persistent and challenging skin infections. This research explores the potential of antifungal susceptibility testing as a guide for managing these infections.

The Need for Effective Treatment

Dermatophyte infections, such as tinea corporis, can be difficult to treat, especially in cases of recurrent or recalcitrant infections. This study examines the relationship between previous antifungal exposure and clinical outcomes, highlighting the importance of antifungal susceptibility testing in guiding treatment decisions.

Antifungal Susceptibility Testing: A Map to Success

The authors suggest that antifungal susceptibility testing, which determines the susceptibility of a fungus to a particular antifungal drug, can be a valuable tool for managing dermatophyte infections. This testing helps clinicians select the most appropriate treatment for each patient, potentially improving clinical outcomes.

Dr. Camel's Conclusion

This research emphasizes the need for a more personalized approach to managing dermatophyte infections. Antifungal susceptibility testing provides a roadmap through the desert of fungal infections, helping clinicians make informed decisions and guide patients toward a successful recovery.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-12-27
Further Info :

Pubmed ID

36547624

DOI: Digital Object Identifier

PMC9785514

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.